@mascot
Hi. It’s been on my radar from the beginning and I have a hunch that it is a good plan for me given all of the cofactors. My hematologist agrees and the oncologist is one of the researchers on the trial. It’s also a treatment that has been fda approved for late stage so there is a track record of safety and effectiveness. There is risk and I am working to stay present with that. As well as keep a clear mind. Thanks for the question.